Company intelligence / Profile preview

Sofwave

Yokneam Illit/Yoqnea'm, Israelsofwave.com ↗

Ownership: Private
Development stage: Commercial

Overview

Sofwave’s ultrasound-based SUPERB™ system has received multiple regulatory clearances including FDA approval for non-invasive treatment of facial lines/wrinkles, eyebrow lifting, submental and neck tissue tightening/lifting in adults 22+, short-term cellulite improvement, and acne scar treatment. Clinical studies have shown high efficacy with minimal downtime; for example, a clinical study supporting FDA clearance for acne scars showed 97% of participants improved as assessed by masked evaluators[7]. Over 460,000 treatments have been performed globally[3].

Therapeutic areas: OtherDermatology
Modalities: DeviceUltrasound-based therapyElectrical muscle stimulation (EMS)
Industry: Therapeutic Medical Devices

Partnerships

Not specifically disclosed in public sources[3][5][7]

Beyond the preview

Go deeper on Sofwave.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sofwave.

Explore the full profile